SEC Form 4 reporting owner

Lezack Adam

Lezack Adam has filed 6 Form 4 transactions reported between December 1, 2025 and May 22, 2026, as a reporting owner of Beta Bionics, Inc..

Name as filed: Lezack Adam

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$63K
4 lines
Companies
1
with Form 4 filings
Latest transaction
May 22, 2026
transaction date

Roles and reported holdings

  • BBNXBeta Bionics, Inc.
    Dec 1, 2025 – May 22, 2026

    Reporting owner

    Held directly27,399 sh as of May 22, 2026 · Form 4

    24 months: $63K sold

Transaction history

All 6 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
May 22, 2026BBNXOpen-market saleCode S · direct998$11K@ $11.21Form 4
May 21, 2026BBNXGrant or awardCode A · direct16,965—Form 4
May 21, 2026BBNXOpen-market saleCode S · direct1,000$10K@ $9.95Form 4
Jan 13, 2026BBNXGrant or awardCode A · direct3,997—Form 4
Dec 1, 2025BBNXOpen-market saleCode S · direct500$15K@ $29.91Form 4
Dec 1, 2025BBNXOpen-market saleCode S · direct906$27K@ $29.35Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.